It is a healthcare private limited company based in Satara, Maharashtra, India, established in 2014.
2014 | Satara, Maharashtra, India | ActiveMedtabs Pharma Private Limited, a active private limited company, was established on 03 July 2014 in Satara, Maharashtra, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U85100PN2014PTC151685. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Prashant Ganpati Wankar (Director), Sagar Pramod Doshi (Director), Angha Sanjay Apte (Director). Past directors included Prashant Ganpati Wankar, Manisha Prashant Wankar, Kishor Ganapati Wankar. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 14 December 2024, with the balance sheet filed on 31 March 2024. It is based at 518, Shaniwar Peth,, Satara, Maharashtra, 415002.
U85100PN2014PTC151685
151685
03 July 2014
₹0.50 M
₹0.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Medtabs Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Ganpati Wankar | Director | 27 Sep 2014 | Current |
| Sagar Pramod Doshi | Director | 03 Jul 2014 | Current |
| Angha Sanjay Apte | Director | 27 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 15 Sep 2018 | Past |
| Pramod Abcsdd | Director | 15 Sep 2018 | Past |
| Pramod Abcsdd | Director | 15 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medtabs Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 103.84% increase. The company also saw a substantial improvement in profitability, with a 318.94% increase in profit. The company's net worth moved up by a moderate rise of 2.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Medtabs Pharma had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2024 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medtabs Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medtabs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medtabs Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Medtabs Pharma Private Limited last Annual general meeting of members was held on 14 Dec 2024 as per latest MCA records. was documented.
The activity A charge with Others amounted to Rs. 5.00 M with Charge ID 100922630 was registered on 29 Apr 2024. was completed.
Progress on Medtabs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity Prashant Ganpati Wankar was appointed as a Director was appointed as a Director on 27 Sep 2014 & has been associated with this company since 11 years 2 months . was completed.
Progress on Angha Sanjay Apte was appointed as a Director was appointed as a Director on 27 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
The activity Sagar Pramod Doshi was appointed as a Director was appointed as a Director on 03 Jul 2014 & has been associated with this company since 11 years 5 months . was completed.
The CIN of Medtabs Pharma Private Limited is U85100PN2014PTC151685.
Medtabs Pharma Private Limited is headquartered at 518, Shaniwar Peth,, Satara, Maharashtra, 415002.
Medtabs Pharma Private Limited was incorporated on 03 July 2014.
The current directors of Medtabs Pharma Private Limited are
The primary industry of Medtabs Pharma Private Limited is Trade.
Medtabs Pharma Private Limited is unlisted.
The authorized capital of Medtabs Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Medtabs Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX